Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma

Cancer Research

Volumn 64, Issue 22, 2004, Pages 8456-8460

  Vuylsteke, Ronald J C L M ^a   Molenkamp, Barbara G ^a   Gietema, Hester A ^a   Van Leeuwen, Paul A M ^a   Wijnands, Pepijn G J T B ^a   Vos, Wim ^a   Van Diest, Paul J ^a   Scheper, Rik J ^a   Meijer, Sybren ^a   De Gruijl, Tanja D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD68 ANTIGEN; CD83 ANTIGEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; T6 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL MATURATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; EARLY CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LOCAL THERAPY; MALE; MELANOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE; SINGLE BLIND PROCEDURE; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; AGED; DENDRITIC CELLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; SINGLE-BLIND METHOD;

EID: 8544239395     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3251     Document Type: Article

References (26)

1. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
2. Toriyama K, Wen DR, Paul E, Cochran AJ. Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. J Investig Dermatol 1993;100:269S-73S.
3. Steinman RM, Pack M, lnaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev 1997;156:25-37.
4. Banchereau S, Palucka AK, Dhodapkar M, et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res 2001;61:6451-8.
5. Butterfield LH, Ribas A, Dissette VB, et al. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin Cancer Res 2003;9:998-1008.
6. Romero P, Dunbar PR, Valmori D, et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen- experienced tumor-specific cytolytic T lymphocytes. J Exp Med 1998;188:1641-50.
7. Enk AH, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 1997;73:309-16.
8. Peguet-Navarro I, Sportouch M, Popa I, Berthier O, Schmitt D, Portoukalian J. Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis. J Immunol 2003;170:3488-94.
9. Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999;17:3238-44.
10. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83.
11. Statius Muller MG, Borgstein PJ, Pijpers R, et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 2000;7:461-8.
12. Cochran AJ, Morton DL, Stern S, Lana AM, Essner R, Wen DR. Sentinel lymph nodes show profound down-regulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 2001;14:604-8.
13. Essner R, Kojima M. Dendritic cell function in sentinel nodes. Oncology (Huntingt.) 2002;16:27-31.
14. Lana AM, Wen D, Cochran AJ. The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res 2001;11:401-10.
15. Kass E, Panicali DL, Mazzara G, Schlom J, Greiner JW. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant. Cancer Res 2001;61:206-14.
16. Vuylsteke RJCLM, van Leeuwen PAM, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 2003;21:1057-65.
17. van Diest PJ. Histopathological work-up of sentinel lymph nodes: how much is enough? J Clin Pathol (Lond.) 1999;52:871-3.
18. Vuylsteke RJCLM, van Leeuwen PAM, Meijer S, et al. Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells. Am J Pathol 2002;161:19-26.
19. van Hensbergen Y, Luykx-de Bakker SA, Heideman DA, Meijer GA, Pinedo HM, van Diest PJ. Rapid stereology based quantitative immunohistochemistry of dendritic cells in lymph nodes: a methodological study. Anal Cell Pathol 2001;22:143-9.
20. Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev 2002;188:147-54.
21. Pinedo HM, Buter J, Luykx-de Bakker SA, et al. Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer 2003;39:1061-7.
22. Movassagh M, Spatz A, Davoust J, et al. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res 2004;64:2192-8.
23. Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000;177:134-40.
24. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-9.
25. Bousso P, Robey E. Dynamics of CD8+ T-cell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003;4:579-85.
26. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004;10:2351-8.